TransDigm Group Files Q3 2024 10-Q

TL;DR

TDG filed its Q3 10-Q. Financials are in.

AI Summary

TransDigm Group Inc. filed its 10-Q for the period ending June 29, 2024. The filing covers the third quarter of their fiscal year. Key financial details and operational updates are provided for investors and stakeholders.

Why It Matters

This filing provides crucial financial performance data for TransDigm Group, impacting investor decisions and market perception of the aerospace and defense company.

Risk Assessment

Risk Level: medium — As a publicly traded company in the aerospace sector, TransDigm faces inherent market, operational, and regulatory risks.

Key Numbers

• 2024 Q3 — Fiscal Quarter (Reporting period for this 10-Q filing.)
• 0930 — Fiscal Year End (Indicates the end of TransDigm's fiscal year.)

Key Players & Entities

• TransDigm Group INC (company) — Filer
• 20240629 (date) — Period of Report
• 20240806 (date) — Filed as of Date
• CLEVELAND (location) — Business Address City

FAQ

Key Financial Figures

• $0.01 — nge on which registered: Common Stock, $0.01 par value TDG New York Stock Exchange
• $35 — t — — — — — — — 1 1 Special dividends ($35 per share) and dividend equivalents — —

Filing Documents

• tdg-20240629.htm (10-Q) — 2004KB
• exhibit31amendedandrestate.htm (EX-3.1) — 10KB
• exhibit32firstamendedandre.htm (EX-3.2) — 61KB
• exhibit33certificateofinco.htm (EX-3.3) — 12KB
• exhibit34certificateofamen.htm (EX-3.4) — 5KB
• exhibit35certificateofamen.htm (EX-3.5) — 8KB
• exhibit36thirdamendedandre.htm (EX-3.6) — 72KB
• exhibit37thirdamendedandre.htm (EX-3.7) — 34KB
• exhibit38firstamendedandre.htm (EX-3.8) — 33KB
• exhibit39amendedandrestate.htm (EX-3.9) — 11KB
• exhibit310restatedbylawsof.htm (EX-3.10) — 63KB
• exhibit311certificateofinc.htm (EX-3.11) — 24KB
• exhibit312certificateofcor.htm (EX-3.12) — 8KB
• exhibit313firstamendedandr.htm (EX-3.13) — 65KB
• exhibit314certificateoffor.htm (EX-3.14) — 14KB
• exhibit315certificateofcor.htm (EX-3.15) — 18KB
• exhibit316firstamendedandr.htm (EX-3.16) — 36KB
• exhibit101seventeenthamend.htm (EX-10.1) — 44KB
• exhibit22tdg2024q310-q.htm (EX-22) — 74KB
• exhibit311tdg2024q310-q.htm (EX-31.1) — 9KB
• exhibit312tdg2024q310-q.htm (EX-31.2) — 10KB
• exhibit321tdg2024q310-q.htm (EX-32.1) — 5KB
• exhibit322tdg2024q310-q.htm (EX-32.2) — 5KB
• 0001260221-24-000069.txt ( ) — 10441KB
• tdg-20240629.xsd (EX-101.SCH) — 61KB
• tdg-20240629_cal.xml (EX-101.CAL) — 84KB
• tdg-20240629_def.xml (EX-101.DEF) — 305KB
• tdg-20240629_lab.xml (EX-101.LAB) — 636KB
• tdg-20240629_pre.xml (EX-101.PRE) — 496KB
• tdg-20240629_htm.xml (XML) — 1689KB

FINANCIAL INFORMATION 1

PART I FINANCIAL INFORMATION 1

Financial Statements 1

ITEM 1 Financial Statements 1 Condensed Consolidated Balance Sheets – June 29, 2024 and September 30, 2023 1 Condensed Consolidated Statements of Income – Thirteen and Thirty-Nine Week Periods Ended June 29, 2024 and July 1, 2023 2 Condensed Consolidated Statements of Comprehensive Income – Thirteen and Thirty-Nine Week Periods Ended June 29, 2024 and July 1, 2023 3 Condensed Consolidated Statements of Changes in Stockholders' Deficit – Thirteen and Thirty-Nine Week Periods Ended June 29, 2024 and July 1, 2023 4 Condensed Consolidated Statements of Cash Flows – Thirty-Nine Week Periods Ended June 29, 2024 and July 1, 2023 6 Notes to Condensed Consolidated Financial Statements 7

Management's Discussion and Analysis of Financial Condition and Results of Operations 30

ITEM 2 Management's Discussion and Analysis of Financial Condition and Results of Operations 30

Quantitative and Qualitative Disclosure About Market Risk 53

ITEM 3 Quantitative and Qualitative Disclosure About Market Risk 53

Controls and Procedures 53

ITEM 4 Controls and Procedures 53

OTHER INFORMATION 54

PART II OTHER INFORMATION 54

Legal Proceedings 54

ITEM 1 Legal Proceedings 54

Risk Factors 54

ITEM 1A Risk Factors 54

Unregistered Sales of Equity Securities and Use of Proceeds: Purchases of Equity Securities by the Issuer 54

ITEM 2 Unregistered Sales of Equity Securities and Use of Proceeds: Purchases of Equity Securities by the Issuer 54

Exhibits 55

ITEM 6 Exhibits 55 SIGNATURES 56 Table of Contents

: FINANCIAL INFORMATION

PART I: FINANCIAL INFORMATION

FINANCIAL STATEMENTS

ITEM 1. FINANCIAL STATEMENTS TRANSDIGM GROUP INCORPORATED CONDENSED CONSOLIDATED BALANCE SHEETS (Amounts in millions, except share amounts) (Unaudited) June 29, 2024 September 30, 2023 ASSETS CURRENT ASSETS: Cash and cash equivalents $ 3,360 $ 3,472 Trade accounts receivable—Net 1,300 1,230 Inventories—Net 1,878 1,616 Prepaid expenses and other 523 420 Total current assets 7,061 6,738 PROPERTY, PLANT AND EQUIPMENT—NET 1,431 1,255 GOODWILL 10,018 8,988 OTHER INTANGIBLE ASSETS—NET 3,116 2,747 OTHER NON-CURRENT ASSETS 202 242 TOTAL ASSETS $ 21,828 $ 19,970 LIABILITIES AND STOCKHOLDERS' DEFICIT CURRENT LIABILITIES: Current portion of long-term debt $ 78 $ 71 Short-term borrowings—trade receivable securitization facility 450 349 Accounts payable 320 305 Accrued and other current liabilities 1,003 854 Total current liabilities 1,851 1,579 LONG-TERM DEBT 21,364 19,330 DEFERRED INCOME TAXES 708 627 OTHER NON-CURRENT LIABILITIES 415 412 Total liabilities 24,338 21,948 TD GROUP STOCKHOLDERS' DEFICIT: Common stock - $ .01 par value; authorized 224,400,000 shares; issued 61,774,108 and 60,995,513 at June 29, 2024 and September 30, 2023, respectively 1 1 Additional paid-in capital 2,749 2,440 Accumulated deficit ( 3,416 ) ( 2,621 ) Accumulated other comprehensive loss ( 146 ) ( 98 ) Treasury stock, at cost; 5,688,639 shares at June 29, 2024 and September 30, 2023, respectively ( 1,706 ) ( 1,706 ) Total TD Group stockholders' deficit ( 2,518 ) ( 1,984 ) NONCONTROLLING INTERESTS 8 6 Total stockholders' deficit ( 2,510 ) ( 1,978 ) TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT $ 21,828 $ 19,970 See notes to condensed consolidated financial statements 1 Table of Contents TRANSDIGM GROUP INCORPORATED CONDENSED CONSOLIDATED STATEMENTS OF INCOME (Amounts in millions, except per share amounts) (Unaudited) Thirteen Week Periods Ended Thirty-Nine Week Periods Ended June 29, 2024 July 1, 2023 June 29, 2024 July 1, 2023 NET SALES $ 2,046

View Full Filing

View this 10-Q filing on SEC EDGAR